Reaxense

Reaxense is a Canadian biotech company offering an AI-driven platform (REAXENSE) for designing, synthesizing, and supplying small molecules, peptides, and macrocycles for drug discovery. Their platform combines in-stock/virtual compound libraries, peptide and macrocycle design, and protein characterization. Utilizing tools like ChemoVista, VirtuSynthium, OmniPeptide Nexus, MacroCyclePro, and Receptor360, Reaxense supports hit identification, lead optimization, and custom synthesis. While not independently conducting clinical programs, Reaxense empowers partners' preclinical and translational drug discovery efforts with rapid, data-driven compound development and custom molecules, notably partnering with Receptor.AI as a core chemistry/synthesis engine.[1][2][4]